DD258604A5 - Verfahren zur herstellung von neuen ungesaettigten verbindungen - Google Patents
Verfahren zur herstellung von neuen ungesaettigten verbindungen Download PDFInfo
- Publication number
- DD258604A5 DD258604A5 DD86293596A DD29359686A DD258604A5 DD 258604 A5 DD258604 A5 DD 258604A5 DD 86293596 A DD86293596 A DD 86293596A DD 29359686 A DD29359686 A DD 29359686A DD 258604 A5 DD258604 A5 DD 258604A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- group
- formula
- phenyl
- lower alkyl
- aik
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Paper (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH350485 | 1985-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD258604A5 true DD258604A5 (de) | 1988-07-27 |
Family
ID=4257414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD86293596A DD258604A5 (de) | 1985-08-14 | 1986-08-12 | Verfahren zur herstellung von neuen ungesaettigten verbindungen |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4808603A (ja) |
| EP (1) | EP0214094A1 (ja) |
| JP (1) | JPS6239569A (ja) |
| KR (1) | KR870002077A (ja) |
| AU (1) | AU6110386A (ja) |
| DD (1) | DD258604A5 (ja) |
| DK (1) | DK386086A (ja) |
| ES (1) | ES2000865A6 (ja) |
| FI (1) | FI863238A (ja) |
| GR (1) | GR862105B (ja) |
| HU (1) | HU196961B (ja) |
| NO (1) | NO863269L (ja) |
| PT (1) | PT83192B (ja) |
| ZA (1) | ZA866082B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63135381A (ja) * | 1986-11-26 | 1988-06-07 | Kyorin Pharmaceut Co Ltd | 多剤耐性癌細胞に対する感受性増強剤及びその製造方法 |
| US5434179A (en) * | 1989-06-06 | 1995-07-18 | Takeda Chemical Industries, Ltd. | Method for improving brain function using cholinesterase-inhibiting aminoketone compounds |
| JP2861274B2 (ja) * | 1989-06-06 | 1999-02-24 | 武田薬品工業株式会社 | アミノケトン誘導体 |
| FR2671349B1 (fr) * | 1991-01-09 | 1993-04-23 | Lafon Labor | Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0145956A1 (de) * | 1983-11-16 | 1985-06-26 | Ciba-Geigy Ag | Neue Amid-Verbindungen |
| JPS60156671A (ja) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体およびその製造法 |
-
1986
- 1986-08-07 US US06/895,604 patent/US4808603A/en not_active Expired - Fee Related
- 1986-08-08 EP EP86810349A patent/EP0214094A1/de not_active Withdrawn
- 1986-08-08 FI FI863238A patent/FI863238A/fi not_active Application Discontinuation
- 1986-08-11 GR GR862105A patent/GR862105B/el unknown
- 1986-08-12 DD DD86293596A patent/DD258604A5/de not_active IP Right Cessation
- 1986-08-12 ES ES8601041A patent/ES2000865A6/es not_active Expired
- 1986-08-13 AU AU61103/86A patent/AU6110386A/en not_active Abandoned
- 1986-08-13 HU HU863574A patent/HU196961B/hu not_active IP Right Cessation
- 1986-08-13 PT PT83192A patent/PT83192B/pt unknown
- 1986-08-13 NO NO863269A patent/NO863269L/no unknown
- 1986-08-13 DK DK386086A patent/DK386086A/da not_active Application Discontinuation
- 1986-08-13 ZA ZA866082A patent/ZA866082B/xx unknown
- 1986-08-14 KR KR1019860006713A patent/KR870002077A/ko not_active Application Discontinuation
- 1986-08-14 JP JP61189711A patent/JPS6239569A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO863269L (no) | 1987-02-16 |
| HUT41733A (en) | 1987-05-28 |
| NO863269D0 (no) | 1986-08-13 |
| DK386086D0 (da) | 1986-08-13 |
| US4808603A (en) | 1989-02-28 |
| KR870002077A (ko) | 1987-03-30 |
| JPS6239569A (ja) | 1987-02-20 |
| EP0214094A1 (de) | 1987-03-11 |
| ES2000865A6 (es) | 1988-03-16 |
| GR862105B (en) | 1986-12-30 |
| FI863238A0 (fi) | 1986-08-08 |
| PT83192B (en) | 1988-09-22 |
| ZA866082B (en) | 1987-03-25 |
| HU196961B (en) | 1989-02-28 |
| DK386086A (da) | 1987-02-15 |
| PT83192A (en) | 1986-09-01 |
| AU6110386A (en) | 1987-02-19 |
| FI863238A (fi) | 1987-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69718026T2 (de) | Fluorierte 1,4-disubstituierte piperidin-derivate | |
| DE3906920C2 (de) | Piperazinderivate oder deren Salze, Verfahren zur Herstellung derselben und pharmazeutische Mittel mit einem Gehalt derselben als Wirkstoff | |
| DD237165A5 (de) | Verfahren zur herstellung von carbonylverbindungen und deren salzen | |
| DE19837386A1 (de) | CCR-3-Rezeptorantagonisten | |
| DE69601527T2 (de) | Pyrrolylbenzimidazol-Derivate | |
| EP0111453A1 (de) | Amid-Verbindungen | |
| DE69012650T2 (de) | Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung. | |
| DD209456A5 (de) | Verfahren zur herstellung von n-oxid-verbindungen | |
| EP1259492A1 (de) | Substituierte piperazinderivate als inhibitoren des mtp | |
| DE69910568T2 (de) | Furopyridinderivate und ihre therapeutische verwendung | |
| DE2306671A1 (de) | Neue pyridinverbindungen und verfahren zu ihrer herstellung | |
| DE69522332T2 (de) | 1,4-dihydropyridine als bradykinin antagonisten | |
| CH638216A5 (de) | Oxadiazolopyrimidin-deriate. | |
| DD228547A5 (de) | Verfahren zur herstellung von neuen amid-verbindungen | |
| DD258604A5 (de) | Verfahren zur herstellung von neuen ungesaettigten verbindungen | |
| EP0111455A2 (de) | Ungesättigte Lactone | |
| CH678322A5 (ja) | ||
| EP1204664A1 (en) | Chemokine receptor antagonists and methods of use therefor | |
| EP0222702A2 (de) | Basische Carbonylverbindungen | |
| DE3314196A1 (de) | Heterocyclylaether | |
| DE3445356A1 (de) | Halogenierte thiophen-verbindungen | |
| DE60013607T2 (de) | Bemzimidazolverbindungen und medikamente die diese enthalten | |
| DE69714019T2 (de) | 1,4-dihydropyridin-verbindungen als bradykinin-antagonisten | |
| JPS59116267A (ja) | ２−ヒドロキシメチル−３−カルバモイル−１，４−ジヒドロピリジン化合物、その製造方法及び前記化合物を含有する医薬用調製物 | |
| EP0162217A1 (de) | 1,2,4-Triazacycloalkadienderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ENJ | Ceased due to non-payment of renewal fee |